G779-0399 Screening compound: 3-(3-{1-[(3-chlorophenyl)methyl]-1,2,3,6-tetrahydropyridin-4-yl}-1,2,4-oxadiazol-5-yl)-N-cyclohexylpropanamide

G779-0399 Screening compound: 3-(3-{1-[(3-chlorophenyl)methyl]-1,2,3,6-tetrahydropyridin-4-yl}-1,2,4-oxadiazol-5-yl)-N-cyclohexylpropanamide
G779-0399 Screening compound: 3-(3-{1-[(3-chlorophenyl)methyl]-1,2,3,6-tetrahydropyridin-4-yl}-1,2,4-oxadiazol-5-yl)-N-cyclohexylpropanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G779-0399
3-(3-{1-[(3-chlorophenyl)methyl]-1,2,3,6-tetrahydropyridin-4-yl}-1,2,4-oxadiazol-5-yl)-N-cyclohexylpropanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G779-0399

Molecular Formula

C23H29ClN4O2 (C23 H29 ClN4 O2)

Compound Name

3-(3-{1-[(3-chlorophenyl)methyl]-1,2,3,6-tetrahydropyridin-4-yl}-1,2,4-oxadiazol-5-yl)-N-cyclohexylpropanamide

IUPAC name

3-(3-{1-[(3-chlorophenyl)methyl]-1236-tetrahydropyridin-4-yl}-124-oxadiazol-5-yl)-N-cyclohexylpropanamide

SMILES

O=C(CCc1nc(C2=CCN(Cc3cccc(Cl)c3)CC2)no1)NC1CCCCC1

InChI

InChI=1S/C23H29ClN4O2/c24-19-6-4-5-17(15-19)16-28-13-11-18(12-14-28)23-26-22(30-27-23)10-9-21(29)25-20-7-2-1-3-8-20/h4-6,11,15,20H,1-3,7-10,12-14,16H2,(H,25,29)

InChI Key

MAZYMCWYYPEVRD-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15035450

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

428.96

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

4.634

Distribution Coefficient, logD

4.605

Water Solubility, LogSw

-4.73

Polar Surface Area

59.239

Acid Dissociation Constant (pKa)

15.48

Base Dissociation Constant (pKb)

6.23

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

52.20

G779-0399 in Drug Discovery

Included in Screening Libraries

3D-Diversity Natural-Product-Like Library (18102 compounds)

CNS Targets (44014 compounds)

GPCR Targeted Library (31838 compounds)

Neurotransmitter Transporter Inhibitors Library (11024 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
Therapeutical areas:
  • Nervous system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Nervous system
Targets:
  • GPCR
  • GPCR
  • Ion Channels
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with G779-0399 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G779-0399?
Check Price and Availability of G779-0399, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G779-0399 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G779-0399
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G779-0399
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G779-0399 available by request